Considering the multiple defects caused by excessive CaMK II activity in myocardial Ca2+ homeostasis, CaMK II inhibition is used to prevent myocardial injury, such as in myocardial ischemia-reperfusion, myocardial infarction, and Ca2+-related heart injury [24]. Here, CAMK2G is linked to myocardial infarction.